Clinical Study
High Sensitivity Troponins Discriminate Different Morphologies of Coronary Artery Plaques Being Assessed by Coronary Computed Tomography Angiography
Table 1
Baseline characteristics of study patients.
| | Characteristics | RV function () |
| | Age, mean (range) | 60 (18–84.1) | | Gender, n (%) | | Male | 54 (54) | | Female | 46 (47) | | Cardiovascular risk factors, n (%) | | Arterial hypertension | 56 (57) | | Hypercholesterinaemia | 39 (39) | | Cardiac family history | 23 (23) | | Smoking | 34 (34) | | Diabetes mellitus | 17 (17) | | Adipositas | 32 (32) | | Laboratory parameters, median (IQRa) | | Creatinine, μmol/l | 75.14 (64.5–87.5) | | eGFR ml/min | 88.19 (72.8–100.99) | | Total cholesterol, mmol/l | 4.81 (4.1–5.6) | | LDL cholesterol, mmol/l | 3.08 (2.5–4.1) | | HDL cholesterol, mmol/l | 1.24 (1.0-1.6) | | Triglyceride, mmol/l | 1.45 (0.9–2.0) | | Uric acid μmol/l | 291.45 (249.8–356.9) | | hsTnI, pg/ml | 2.2 (1.3–4.5) | | hsTnT, ng/ml | 0.006 (0.003–0.01) | | Atrial fibrillation | | Paroxysmal | 8 (8) | | Persistent | 8 (8) | | Permanent | 2 (2) | | Coronary artery disease | | 1 vessel disease | 16 (16) | | 2 vessel disease | 8 (8) | | 3 vessel disease | 2 (2) | | Coronary artery disease | | None | 43 (43) | | Nonobstructive (<50%) | 30 (30) | | Obstructive (>50%) | 26 (26) | | COPD | 7 (7) | | Cancer | 19 (19) | | pAD | 4 (4) | | LVEF, median (IQRa) | 62 (52–68) |
|
|
ainterquartile range. eGFR: estimated glomerular filtration rate; LVEF: left ventricular ejection fraction; COPD: chronic obstructive pulmonary disease; pAD: peripheral arterial disease.
|
